Works matching AU Bartlett, Nancy

Results: 128

Cross-Sex Wishes and Gender Identity Disorder in Children: A Reply to Zucker (2002).

Published in:

Sex Roles, 2003, v. 49, n. 3-4, p. 191, doi. 10.1023/A:1024421216606

By:

Bartlett, Nancy H.;
Vasey, Paul L.;
Bukowski, William M.

Publication type:

Article

Is Gender Identity Disorder in Children a Mental Disorder?

Published in:

Sex Roles, 2000, v. 43, n. 11-12, p. 753, doi. 10.1023/A:1011004431889

By:

Bartlett, Nancy H.;
Vasey, Paul L.;
Bukowski, William M.

Publication type:

Article

A Young Woman With Blurred Vision and Distal Paresthesias.

Published in:

JAMA Neurology, 2015, v. 72, n. 12, p. 1519, doi. 10.1001/jamaneurol.2015.2390

By:

Kung, Nathan H.;
Bartlett, Nancy L.;
Yaseen, Nabeel R.;
Van Stavern, Gregory P.;
Bucelli, Robert C.

Publication type:

Article

Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers.

Published in:

Therapeutic Advances in Hematology, 2014, v. 5, n. 1, p. 3, doi. 10.1177/2040620713514682

By:

Wildes, Tanya M.;
Farrington, Laura;
Yeung, Cecilia;
Harrington, Alexandra M.;
Foyil, Kelley V.;
Liu, Jingxia;
Kreisel, Friederike;
Bartlett, Nancy L.;
Fenske, Timothy S.

Publication type:

Article

Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma.

Published in:

Cancers, 2022, v. 14, n. 12, p. 2932, doi. 10.3390/cancers14122932

By:

Jaswal, Shama;
Sanders, Vanessa;
Pullarkat, Priyanka;
Teja, Stephanie;
Salter, Amber;
Watkins, Marcus P.;
Atagu, Norman;
Ludwig, Daniel R.;
Mhlanga, Joyce;
Mellnick, Vincent M.;
Peterson, Linda R.;
Bartlett, Nancy L.;
Kahl, Brad S.;
Fehniger, Todd A.;
Ghobadi, Armin;
Cashen, Amanda F.;
Mehta-Shah, Neha;
Ippolito, Joseph E.

Publication type:

Article

Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.

Published in:

Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01448-y

By:

Epperla, Narendranath;
Welkie, Rina Li;
Torka, Pallawi;
Shouse, Geoffrey;
Karmali, Reem;
Shea, Lauren;
Anampa-Guzmán, Andrea;
Oh, Timothy S.;
Reaves, Heather;
Tavakkoli, Montreh;
Lindsey, Kathryn;
Greenwell, Irl Brian;
Hansinger, Emily;
Thomas, Colin;
Chowdhury, Sayan Mullick;
Annunzio, Kaitlin;
Christian, Beth;
Barta, Stefan K.;
Geethakumari, Praveen Ramakrishnan;
Bartlett, Nancy L.

Publication type:

Article

Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 3, p. 350, doi. 10.2967/jnumed.112.111948

By:

Dehdashti, Farrokh;
Laforest, Richard;
Feng Gao;
Shoghi, Kooresh I.;
Aft, Rebecca L.;
Nussenbaum, Brian;
Kreisel, Friederike H.;
Bartlett, Nancy L.;
Cashen, Amanda;
Wagner-Johnson, Nina;
Mach, Robert H.

Publication type:

Article

18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation.

Published in:

Journal of Nuclear Medicine, 2011, v. 52, n. 3, p. 386, doi. 10.2967/jnumed.110.082586

By:

Cashen, Amanda F.;
Dehdashti, Farrokh;
Luo, Jingqin;
Homb, Andrew;
Siegel, Barry A.;
Bartlett, Nancy L.

Publication type:

Article

Mosunetuzumab Monotherapy Demonstrates Durable Efficacy and Manageable Safety in Patients With Relapsed/Refractory Follicular Lymphoma and =2 Prior Therapies: Updated Results From a Pivotal Phase 2 Study.

Published in:

Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 359

By:

Bartlett, Nancy L.;
Sehn, Laurie H.;
Matasar, Matthew;
Schuster, Stephen J.;
Assouline, Sarit;
Giri, Pratyush;
Kuruvilla, John;
Canales, Miguel;
Dietrich, Sascha;
Fay, Keith;
Ku, Matthew;
Nastoupil, Loretta;
Wei, Michael C.

Publication type:

Article

Interdisciplinary Management of Chemorefractory NHL Patients Treated with KTE-C19 (Anti-CD19 CAR T Cells) in Phase 1 of the ZUMA-1 Clinical Study.

Published in:

Journal of Oncology Navigation & Survivorship, 2016, v. 7, n. 9, p. 56

By:

Beaupierre, Alix;
Patterson, Amy;
Kahle, Nicole;
Locke, Frederick L.;
Neelapu, Sattva S.;
Bartlett, Nancy L.;
Siddiqi, Tanya;
Chavez, Julio C.;
Hosing, Chitra M.;
Cashen, Amanda;
Budde, Lihua E.;
Navale, Lynn;
Yizhou Jiang;
Elias, Meg;
Aycock, Jeff;
Wiezorek, Jeff;
Go, William Y.

Publication type:

Article

A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 5, p. 328, doi. 10.1016/j.clml.2024.11.015

By:

Foley, Nicole;
Riedell, Peter A.;
Bartlett, Nancy L.;
Cashen, Amanda F.;
Kahl, Brad S.;
Fehniger, Todd A.;
Fischer, Anne;
Moreno, Chaz;
Jingxia Liu;
Carson, Kenneth R.;
Mehta-Shah, Neha

Publication type:

Article

Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 552, doi. 10.1016/j.clml.2023.04.003

By:

Patel, Dilan A.;
Wan, Fei;
Trinkaus, Kathryn;
Guy, Daniel G.;
Edwin, Natasha;
Watkins, Marcus;
Bartlett, Nancy L.;
Cashen, Amanda;
Fehniger, Todd A.;
Ghobadi, Armin;
Shah, Neha-Mehta;
Kahl, Brad S.

Publication type:

Article

Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e435, doi. 10.1016/j.clml.2021.12.012

By:

Hamid, Muhammad Saad;
Rutherford, Sarah C.;
Jang, Hyejeong;
Kim, Seongho;
Patel, Krish;
Bartlett, Nancy L.;
Malecek, Mary-Kate;
Watkins, Marcus P.;
Maddocks, Kami J.;
Bond, David A.;
Feldman, Tatyana A.;
Magarelli, Gabriela;
Advani, Ranjana H;
Spinner, Michael A;
Evens, Andrew M.;
Shah, Mansi;
Ahmed, Sairah;
Stephens, Deborah M.;
Allen, Pamela;
Tees, Michael T.

Publication type:

Article

Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e300, doi. 10.1016/j.clml.2021.10.018

By:

Bennani, N. Nora;
Tun, Aung M.;
Carson, Kenneth R;
Geiger, Jessica L;
Maeda, Lauren S;
Savage, Kerry J;
Rose, Jim;
Pinter-Brown, Lauren;
Lunning, Matthew A;
Abramson, Jeremy S;
Bartlett, Nancy L;
Vose, Julie M;
Evens, Andrew M;
Smith, Sonali M;
Horwitz, Steven M;
Ansell, Stephen M.;
Advani, Ranjana H

Publication type:

Article

Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e250, doi. 10.1016/j.clml.2021.10.004

By:

Bennani, N. Nora;
Tun, Aung M.;
Carson, Kenneth R.;
Geiger, Jessica L.;
Maeda, Lauren S.;
Savage, Kerry J.;
Rose, Jim;
Pinter-Brown, Lauren;
Lunning, Matthew A.;
Abramson, Jeremy S.;
Bartlett, Nancy L.;
Vose, Julie M.;
Evens, Andrew M.;
Smith, Sonali M.;
Horwitz, Steven M.;
Ansell, Stephen M.;
Advani, Ranjana H.

Publication type:

Article

TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S411, doi. 10.1016/S2152-2650(21)01925-X

By:

Iyer, Swaminathan;
Trümper, Lorenz;
O'Connor, Owen A.;
Pro, Barbara;
Illidge, Tim;
Advani, Ranjana;
Bartlett, Nancy L.;
Christensen, Jacob Haaber;
Morschhauser, Franck;
Domingo-Domenech, Eva;
Rossi, Giuseppe;
Won Seog Kim;
Feldman, Tatyana;
Menne, Tobias;
Belada, David;
Illès, Árpád;
Tobinai, Kensei;
Kunihiro Tsukasaki;
Su-Peng Yeh;
Shustov, Andrei

Publication type:

Article

IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S406, doi. 10.1016/S2152-2650(21)01916-9

By:

Assouline, Sarit;
Won Seog Kim;
Sehn, Laurie H.;
Schuster, Stephen J.;
Chan Yoon Cheah;
Nastoupil, Loretta J.;
Shadman, Mazyar;
Sung-Soo Yoon;
Matasar, Matthew J.;
Diefenbach, Catherine;
Gregory, Gareth P.;
Bartlett, Nancy L.;
Wei, Michael C.;
Doral, Michelle Y.;
Shen Yin;
Negricea, Raluca;
Chi-Chung Li;
Penuel, Elicia;
Huang Huang;
Budde, L. Elizabeth

Publication type:

Article

HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S371, doi. 10.1016/S2152-2650(21)01849-8

By:

Ramchandren, Radhakrishnan;
Dfugosz-Danecka, Monika;
Connors, Joseph M.;
Radford, John;
Illés, Árpád;
Picardi, Marco;
Lech-Maranda, Ewa;
Feldman, Tatyana;
Smolewski, Piotr;
Savage, Kerry J.;
Bartlett, Nancy L.;
Walewski, Jan;
Zinzani, Pier Luigi;
Hutchings, Martin;
Munoz, Javier;
Won Seog Kim;
Advani, Ranjana;
Ansell, Stephen M.;
Gallamini, Andrea;
Alekseev, Sergey

Publication type:

Article

Poster: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S247, doi. 10.1016/S2152-2650(21)01557-3

By:

Iyer, Swaminathan;
Trümper, Lorenz;
O'Connor, Owen A.;
Pro, Barbara;
Illidge, Tim;
Advani, Ranjana;
Bartlett, Nancy L.;
Christensen, Jacob Haaber;
Morschhauser, Franck;
Domingo-Domenech, Eva;
Rossi, Giuseppe;
Kim, Won Seog;
Feldman, Tatyana;
Menne, Tobias;
Belada, David;
Illès, Árpád;
Tobinai, Kensei;
Tsukasaki, Kunihiro;
Yeh, Su-Peng;
Shustov, Andrei

Publication type:

Article

Poster: IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01540-8

By:

Assouline, Sarit;
Kim, Won Seog;
Sehn, Laurie H.;
Schuster, Stephen J.;
Cheah, Chan Yoon;
Nastoupil, Loretta J.;
Shadman, Mazyar;
Yoon, Sung-Soo;
Matasar, Matthew J.;
Diefenbach, Catherine;
Gregory, Gareth P.;
Bartlett, Nancy L.;
Wei, Michael C.;
Doral, Michelle Y.;
Yin, Shen;
Negricea, Raluca;
Li, Chi-Chung;
Penuel, Elicia;
Huang, Huang;
Budde, L. Elizabeth

Publication type:

Article

Poster: HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S236, doi. 10.1016/S2152-2650(21)01485-3

By:

Ramchandren, Radhakrishnan;
Długosz-Danecka, Monika;
Connors, Joseph M.;
Radford, John;
Illés, Árpád;
Picardi, Marco;
Lech-Maranda, Ewa;
Feldman, Tatyana;
Smolewski, Piotr;
Savage, Kerry J.;
Bartlett, Nancy L.;
Walewski, Jan;
Zinzani, Pier Luigi;
Hutchings, Martin;
Munoz, Javier;
Won Seog Kim;
Advani, Ranjana;
Ansell, Stephen M.;
Gallamini, Andrea;
Alekseev, Sergey

Publication type:

Article

Oral Abstract: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01276-3

By:

Iyer, Swaminathan;
Trümper, Lorenz;
O'Connor, Owen A.;
Pro, Barbara;
Illidge, Tim;
Advani, Ranjana;
Bartlett, Nancy L.;
Christensen, Jacob Haaber;
Morschhauser, Franck;
Domingo-Domenech, Eva;
Rossi, Giuseppe;
Won Seog Kim;
Feldman, Tatyana;
Menne, Tobias;
Belada, David;
Illès, Árpád;
Tobinai, Kensei;
Tsukasaki, Kunihiro;
Su-Peng Yeh;
Shustov, Andrei

Publication type:

Article

Implication of Rituximab Infusion Reactions on Clinical Outcomes in Patients With Diffuse Large B-cell Lymphoma: A Single Institution Experience.

Published in:

2019

By:

Patel, Dilan A.;
Johanns, Tanner M.;
Trinkaus, Kathryn;
Bartlett, Nancy L.;
Wagner-Johnston, Nina;
Cashen, Amanda F.

Publication type:

journal article

Managing Cytokine Release Syndrome and Neurotoxicity with Step-Up Dosing of Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S247, doi. 10.1016/j.clml.2019.07.151

By:

Bartlett, Nancy L.;
Sehn, Laurie H.;
Assouline, Sarit;
Bosch, Francesc;
Diefenbach, Catherine M.;
Flinn, Ian;
Hong, Jung Yong;
Kim, Wonseog S.;
Matasar, Matthew;
Nastoupil, Loretta;
Schuster, Stephen J.;
Shadman, Mazyar;
Yoon, Sung-Soo;
Bender, Brendan;
Chu, Wayne;
Hernandez, Genevive;
Kwan, Antonia;
McCall, Bruce;
Sison, Iris;
Wang, Cunlin

Publication type:

Article

Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome.

Published in:

2019

By:

Fakhri, Bita;
Cashen, Amanda F.;
Duncavage, Eric J.;
Watkins, Marcus P.;
Wartman, Lukas D.;
Bartlett, Nancy L.

Publication type:

journal article

SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma.

Published in:

2018

By:

Watkins, Marcus P.;
Fanale, Michelle A.;
Bartlett, Nancy L.

Publication type:

journal article

SCHOLAR-1 versus ZUMA-1: A Standardized Comparison of Outcomes in Patients (Pts) with Refractory, Aggressive Non-Hodgkin Lymphoma (rNHL).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S362, doi. 10.1016/j.clml.2017.07.197

By:

Neelapu, Sattva;
Locke, Frederick;
Bartlett, Nancy;
Lekakis, Lazaros;
Reagan, Patrick;
Miklos, David;
Jacobson, Caron;
Braunschweig, Ira;
Oluwole, Olalekan;
Siddiqi, Tanya;
Lin, Yi;
Crump, Michael;
Kuruvilla, John;
Van den Neste, Eric;
Link, Brian;
Farooq, Umar;
Navale, Lynn;
Go, Willilam;
Wiezorek, Jeffrey;
Gisselbrecht, Christian

Publication type:

Article

Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.

Published in:

Pharmaceutical Research, 2019, v. 36, n. 7, p. N.PAG, doi. 10.1007/s11095-019-2605-8

By:

Lavezzi, Silvia Maria;
de Jong, Jan;
Neyens, Martine;
Cramer, Paula;
Demirkan, Fatih;
Fraser, Graeme;
Bartlett, Nancy;
Dilhuydy, Marie-Sarah;
Loscertales, Javier;
Avigdor, Abraham;
Rule, Simon;
Samoilova, Olga;
Goy, Andre;
Ganguly, Siddhartha;
Salman, Mariya;
Howes, Angela;
Mahler, Michelle;
De Nicolao, Giuseppe;
Poggesi, Italo

Publication type:

Article

Alzheimer's on film.

Published in:

American Journal of Alzheimer's Disease & Other Dementias, 1989, v. 4, n. 5, p. 42, doi. 10.1177/153331758900400512

By:

Bartlett, Nancy S.

Publication type:

Article

Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).

Published in:

Angewandte Chemie, 2019, v. 131, n. 15, p. 53, doi. 10.1111/bjh.15768

By:

Rosenbaum, Cara A.;
Jung, Sin‐Ho;
Pitcher, Brandelyn;
Bartlett, Nancy L.;
Smith, Sonali M.;
Hsi, Eric;
Wagner‐Johnston, Nina;
Thomas, Sachdev P.;
Leonard, John P.;
Cheson, Bruce D.

Publication type:

Article

Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma.

Published in:

Oncologist, 2022, v. 27, n. 10, p. 864, doi. 10.1093/oncolo/oyac137

By:

Jagadeesh, Deepa;
Horwitz, Steve;
Bartlett, Nancy L;
Kim, Youn;
Jacobsen, Eric;
Duvic, Madeleine;
Little, Meredith;
Trepicchio, William;
Fenton, Keenan;
Onsum, Matthew;
Lisano, Julie;
Advani, Ranjana

Publication type:

Article

Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma.

Published in:

Oncologist, 2022, v. 27, n. 9, p. 864, doi. 10.1093/oncolo/oyac137

By:

Jagadeesh, Deepa;
Horwitz, Steve;
Bartlett, Nancy L;
Kim, Youn;
Jacobsen, Eric;
Duvic, Madeleine;
Little, Meredith;
Trepicchio, William;
Fenton, Keenan;
Onsum, Matthew;
Lisano, Julie;
Advani, Ranjana

Publication type:

Article

Chemotherapy-Induced First Bite Syndrome: A Case Report in a Patient With Hodgkin Lymphoma.

Published in:

ENT: Ear, Nose & Throat Journal, 2019, v. 98, n. 5, p. E30, doi. 10.1177/0145561319840534

By:

Valenzuela, Carla V.;
Bartlett, Nancy L.;
Bradley, Joseph P.

Publication type:

Article

FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUVmax as a predictive biomarker in frontline treatment of mantle cell lymphoma.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 11, p. 1870, doi. 10.1080/10428194.2023.2239404

By:

Russler-Germain, David A.;
Calhoun, Brendan R.;
Wu, Ningying;
Watkins, Marcus P.;
Siegel, Barry A.;
Bartlett, Nancy L.;
Mhlanga, Joyce C.

Publication type:

Article

Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 1, p. 130, doi. 10.1080/10428194.2022.2136956

By:

Kuruvilla, John;
Armand, Philippe;
Hamadani, Mehdi;
Kline, Justin;
Moskowitz, Craig H.;
Avigan, David;
Brody, Joshua D.;
Ribrag, Vincent;
Herrera, Alex F.;
Morschhauser, Franck;
Kanate, Abraham;
Zinzani, Pier Luigi;
Bitran, Jacob;
Ghesquieres, Herve;
Schuster, Stephen J.;
Farooqui, Mohammed;
Marinello, Patricia;
Bartlett, Nancy L.

Publication type:

Article

COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 7, p. 1723, doi. 10.1080/10428194.2022.2038377

By:

Mehta-Shah, Neha;
Bartlett, Nancy L.;
Kahl, Brad;
Watkins, Marcus P.;
Dubois, Amalia;
Schmelzle, Gabby;
Waqar, Saiama;
Ballman, Claire;
Wan, Fei;
Farnsworth, Christopher W.

Publication type:

Article

Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 4, p. 821, doi. 10.1080/10428194.2021.2010057

By:

Halwani, Ahmad S.;
Panizo, Carlos;
Isufi, Iris;
Herrera, Alex F.;
Okada, Craig Y.;
Cull, Elizabeth H.;
Kis, Bela;
Chaves, Jorge M.;
Bartlett, Nancy L.;
Ai, Weiyun;
de la Cruz-Merino, Luis;
Bryan, Locke J.;
Houot, Roch;
Linton, Kim;
Briones, Javier;
Chau, Ian;
von Keudell, Gottfried R.;
Lu, Hailing;
Yakovich, Adam;
Chen, Michael

Publication type:

Article

Survival after autologous versus allogeneic transplantation in patients with relapsed and refractory Hodgkin lymphoma.

Published in:

Leukemia & Lymphoma, 2021, v. 62, n. 10, p. 2408, doi. 10.1080/10428194.2021.1927016

By:

Fakhri, Bita;
Yilmaz, Elif;
Gao, Feng;
Ambinder, Richard F.;
Jones, Richard;
Bartlett, Nancy L.;
Cashen, Amanda;
Wagner-Johnston, Nina

Publication type:

Article

A forgotten friend: CCNU as palliative monotherapy in relapsed Hodgkin lymphoma.

Published in:

2021

By:

Russler-Germain, David A.;
Watkins, Marcus P.;
Bartlett, Nancy L.

Publication type:

Letter

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 13, p. 3188, doi. 10.1080/10428194.2020.1795159

By:

Fraser, Graeme A.M.;
Chanan-Khan, Asher;
Demirkan, Fatih;
Santucci Silva, Rodrigo;
Grosicki, Sebastian;
Janssens, Ann;
Mayer, Jiri;
Bartlett, Nancy L.;
Dilhuydy, Marie-Sarah;
Loscertales, Javier;
Avigdor, Abraham;
Rule, Simon;
Samoilova, Olga;
Pavlovsky, Miguel A.;
Goy, Andre;
Mato, Anthony;
Hallek, Michael;
Salman, Mariya;
Tamegnon, Monelle;
Sun, Steven

Publication type:

Article

Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816.

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 10, p. 2442, doi. 10.1080/10428194.2020.1768388

By:

Ha, Chul S.;
LeBlanc, Michael;
Schöder, Heiko;
Pinnix, Chelsea C.;
Bartlett, Nancy L.;
Evens, Andrew M.;
Hsi, Eric D.;
Rimsza, Lisa;
Knopp, Michael V.;
Zhang, Jun;
Leonard, John P.;
Kahl, Brad S.;
Li, Hongli;
Smith, Sonali;
Constine, Louis S.;
Friedberg, Jonathan W.

Publication type:

Article

The justification of vincristine dose capping: tradition, tradition...tradition!

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 5, p. 1007, doi. 10.1080/10428194.2020.1742907

By:

Bartlett, Nancy L.

Publication type:

Article

Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 2, p. 357, doi. 10.1080/10428194.2017.1330954

By:

Goyal, Sagun;
Oak, Eunhye;
Luo, Jingqin;
Cashen, Amanda F.;
Carson, Kenneth;
Fehniger, Todd;
DiPersio, John;
Bartlett, Nancy L.;
Wagner-Johnston, Nina D.

Publication type:

Article

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry.

Published in:

Leukemia & Lymphoma, 2017, v. 58, n. 7, p. 1607, doi. 10.1080/10428194.2016.1256481

By:

Bartlett, Nancy L.;
Smith, Mitchell R.;
Siddiqi, Tanya;
Advani, Ranjana H.;
O'Connor, Owen A.;
Sharman, Jeff P.;
Feldman, Tatyana;
Savage, Kerry J.;
Shustov, Andrei R.;
Diefenbach, Catherine S.;
Oki, Yasuhiro;
Palanca-Wessels, Maria Corinna;
Uttarwar, Mayur;
Li, Martha;
Yang, Jing;
Jacobsen, Eric D.

Publication type:

Article

Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria.

Published in:

2016

By:

Rashidi, Armin;
Oak, Eunhye;
Carson, Kenneth R.;
Wagner-Johnston, Nina D.;
Kreisel, Friederike;
Bartlett, Nancy L.

Publication type:

Letter to the Editor

Radiation for early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a double-edged sword?

Published in:

Leukemia & Lymphoma, 2016, v. 57, n. 2, p. 249, doi. 10.3109/10428194.2015.1115045

By:

Rashidi, Armin;
Bartlett, Nancy L.

Publication type:

Article

Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 9, p. 2569, doi. 10.3109/10428194.2015.1007504

By:

Fayad, Luis;
Ansell, Stephen M.;
Advani, Ranjana;
Coiffier, Bertrand;
Stuart, Robert;
Bartlett, Nancy L.;
Forero-Torres, Andres;
Kuliczkowski, Kazimierz;
Belada, David;
Ng, Edmund;
Drachman, Jonathan G.

Publication type:

Article

Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies.

Published in:

2015

By:

Forero-Torres, Andres;
Bartlett, Nancy L.;
Berryman, Robert B.;
Chen, Robert;
Matous, Jeffrey V.;
Fanale, Michelle A.;
O'Connor, Owen A.;
Olshefski, Randal;
Smith, Scott E.;
Huebner, Dirk;
Levine, Pamela L.;
Grove, Laurie E.;
Gopal, Ajay K.

Publication type:

Letter to the Editor

Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501).

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 4, p. 958, doi. 10.3109/10428194.2014.938333

By:

Morrison, Vicki A.;
Jung, Sin-Ho;
Johnson, Jeffrey;
LaCasce, Ann;
Blum, Kristie A.;
Bartlett, Nancy L.;
Pitcher, Brandelyn N.;
Cheson, Bruce D.

Publication type:

Article

Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy.

Published in:

Leukemia & Lymphoma, 2014, v. 55, n. 10, p. 2328, doi. 10.3109/10428194.2013.876496

By:

Gopal, Ajay K.;
Bartlett, Nancy L.;
Forero-Torres, Andres;
Younes, Anas;
Chen, Robert;
Friedberg, Jonathan W.;
Matous, Jeffrey V.;
Shustov, Andrei R.;
Smith, Scott E.;
Zain, Jasmine;
O'Meara, Megan M.;
Fanale, Michelle A.

Publication type:

Article